Post by
MinimumDamage on Mar 05, 2021 9:24am
Quick Recap
There's absolutely nothing proprietary in the DNA of the company. We do not own anything of value. All PARTIAL license agreements + a borrowed lab in Australia for a discount of 43%. MONTHLY AMBITIOUS announcements of additional programs. An intertwined team divided in a 3 way split of private companies.
Only holding the PARTIAL rights to R-107 for the treatment of coronaviruses and COVID-19 infection. Due to the cancelled acquisition, Salzman has retained all rights for CILI (Chlorine inhalation lung injury), PAH (Pulmonary arterial hypertension), getting your reproductive organ hard (erectile dysfunction) and everything else where acute lung injuries could be treated.
GVHD the previous soul and pumping blood of the whole enterprise, relinquished. Freedom of many liabilities, debt paiements and difficulty finding a larger Pharma company taking the project over were the main reasons that the project was terminated.
Live long and prosper, do the right thing, abandon ship and salvage the remainder of your investment while you still can.